Statistics for Bioterp (id:6690 BTMD)

Valuation metrics

Market cap

292.63M

Enterprise value

269.98M

Trailing P/E (ttm)

11.12

Forward P/E

9.59

PEG ratio

9.59

Price/Sales (ttm)

1.56

Price/Book (mrq)

-1.41

Enterprise Value/Revenue

1.44

Enterprise Value/EBITDA

6.88

Overview

Shares outstanding

30.99M

Float

12.87M

Shares short

881.50K

% Held by insiders

0.28%

% Held by institutions

0.59%

Average volume (10 days)

88.92K

Average volume (90 days)

Price summary

52-Week low

3.65

52-Week high

8.44

52-Week change

13.53%

Beta

0.94

50-Day moving average

5.53

200-Day moving average

6.00

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

3.67%

Operating margin

16.55%

Operational effectiveness

Return on assets

20.54%

Return on equity

-9.07%

Income statement

Revenue (ttm)

5.64

Revenue per share (ttm)

5.64

Quarterly revenue growth (yoy)

Gross profit (ttm)

127.48M

EBITDA

33.31M

Net income to common (ttm)

6.87M

Diluted EPS (ttm)

0.50

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

26.42M

Total cash per share (mrq)

0.85

Total debt (mrq)

122.38M

Total Debt/Equity (mrq)

-0.86

Current ratio (mrq)

133.50%

Book value per share (mrq)

-4.62

Cash flow

Cash flow statement

24.44M

Levered free cash flow (LFCF)

38.85M